1. Home
  2. BIO vs DSGX Comparison

BIO vs DSGX Comparison

Compare BIO & DSGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • DSGX
  • Stock Information
  • Founded
  • BIO 1952
  • DSGX 1981
  • Country
  • BIO United States
  • DSGX Canada
  • Employees
  • BIO N/A
  • DSGX N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • DSGX Computer Software: Prepackaged Software
  • Sector
  • BIO Industrials
  • DSGX Technology
  • Exchange
  • BIO Nasdaq
  • DSGX Nasdaq
  • Market Cap
  • BIO 9.2B
  • DSGX 9.8B
  • IPO Year
  • BIO N/A
  • DSGX 1999
  • Fundamental
  • Price
  • BIO $279.94
  • DSGX $111.87
  • Analyst Decision
  • BIO Strong Buy
  • DSGX Buy
  • Analyst Count
  • BIO 4
  • DSGX 11
  • Target Price
  • BIO $414.00
  • DSGX $117.00
  • AVG Volume (30 Days)
  • BIO 273.5K
  • DSGX 254.4K
  • Earning Date
  • BIO 02-13-2025
  • DSGX 03-05-2025
  • Dividend Yield
  • BIO N/A
  • DSGX N/A
  • EPS Growth
  • BIO N/A
  • DSGX 20.62
  • EPS
  • BIO N/A
  • DSGX 1.58
  • Revenue
  • BIO $2,566,500,000.00
  • DSGX $631,755,000.00
  • Revenue This Year
  • BIO $4.19
  • DSGX $15.27
  • Revenue Next Year
  • BIO $4.75
  • DSGX $11.59
  • P/E Ratio
  • BIO N/A
  • DSGX $70.74
  • Revenue Growth
  • BIO N/A
  • DSGX 14.90
  • 52 Week Low
  • BIO $262.12
  • DSGX $84.83
  • 52 Week High
  • BIO $387.99
  • DSGX $124.31
  • Technical
  • Relative Strength Index (RSI)
  • BIO 26.04
  • DSGX 39.66
  • Support Level
  • BIO $273.67
  • DSGX $113.82
  • Resistance Level
  • BIO $289.96
  • DSGX $117.35
  • Average True Range (ATR)
  • BIO 11.05
  • DSGX 2.59
  • MACD
  • BIO -6.71
  • DSGX -0.70
  • Stochastic Oscillator
  • BIO 7.40
  • DSGX 1.27

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About DSGX Descartes Systems Group Inc. (The)

Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.

Share on Social Networks: